Table 2.
Summary of published literature relating to the frequency of Epstein-Barr virus in oesophageal cancer.
Reference | Year | Oesophageal cancer type | Total n | EBV positive n (%) | Method |
---|---|---|---|---|---|
TCGA [24] | 2017 | SqC | 90 | 0 | Whole-exome sequencing |
AdC | 70 | 0 | |||
undiff | 2 | 0 | |||
Genitsch et al.[34] | 2015 | AdC | 118 | 0 | EBER ISH |
Farris et al.[38] | 2011 | AdC | 76 | 1 (1) | EBER ISH |
Sunpaweravong et al.[36] | 2005 | SqC | 104 | 0 | EBER ISH |
Wu et al.[39] | 2005 | SqC | 151 | 6 (4) | EBER ISH |
undiff | 13 | 4 (31) | |||
Awerkiew et al.[40] | 2003 | SqC | 23 | 8 (35) | PCR |
AdC | 14 | 5 (36) | |||
Yanai et al.[33] | 2003 | SqC | 34 | 0 | EBER ISH, PCR |
Mizobuchi et al.[37] | 1997 | SqC | 41 | 0 | PCR |
Wang et al.[35] | 1999 | SqC | 51 | 0 | EBER ISH, PCR |
Wang et al.[41] | 1999 | SqC | 31 | 11 (36) | EBER ISH, PCR |
Abbreviations: AdC, adenocarcinoma; SqC, squamous cell carcinoma; EBER ISH, EBV-encoded RNA in situ hybridisation; PCR, polymerase chain reaction; undiff, undifferentiated.